• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因多态性与帕金森病运动性左旋多巴诱导并发症。

Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.

机构信息

Department of Neurology and Epileptology, Centre of Postgraduate Medical Education, Orłowski Hospital, Warsaw, Poland.

Department of Physical Education and Health in Biała Podlaska, Józef Piłsudski University of Physical Education in Warsaw, Biała Podlaska, Poland.

出版信息

Brain Behav. 2020 Mar;10(3):e01537. doi: 10.1002/brb3.1537. Epub 2020 Feb 5.

DOI:10.1002/brb3.1537
PMID:32022467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7066344/
Abstract

OBJECTIVE

The aim of the study was to evaluate the association of individual and combined single-nucleotide polymorphisms in brain-derived neurotrophic factor (BDNF), dopamine transporter (DAT), and catechol-O-methyltransferase (COMT) genes with the occurrence of motor levodopa-induced complications (MLIC) in Parkinson's disease (PD).

MATERIALS AND METHODS

We studied 76 patients with PD (MLIC occurred in 56.6%) and 60 controls. Allelic discrimination of rs6265 BDNF (Val66Met), rs397595 DAT (SLC6A3), and rs4680 COMT (Val158Met) genes were genotyped. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated using multinominal logistic regression. Orthogonal partial least squares (OPLS) analysis and OPLS discriminant analysis (OPLS-DA) were used to analyze qualitative genetic data.

RESULTS

The risk of PD in subjects with the AG BDNF genotype was increased sixfold (OR = 6.12, 95% CI = 2.88-13.02, p < .0001), and AG BDNF and AG DAT genotypes were correlated with PD in OPLS-DA (VIP > 1). There were no differences in distributions of BDNF, DAT and COMT genotypes between PD groups with and without MLIC, while OPLS model showed that genotype combination of AG BDNF, AG DAT, and GG COMT was correlated with MLIC and genotypes combination of GG BDNF, AA DAT, and AA COMT with lack of MLIC in PD patients (VIP > 1).

CONCLUSIONS

Our results confirmed the association of rs6265 BDNF (Val66Met) with the risk of PD and suggest a synergic effect of rs6265 BDNF (Val66Met), rs397595 DAT (SLC6A3), and rs4680 COMT (Val158Met) polymorphisms on the occurrence of MLIC.

摘要

目的

本研究旨在评估脑源性神经营养因子(BDNF)、多巴胺转运体(DAT)和儿茶酚-O-甲基转移酶(COMT)基因的单个和联合单核苷酸多态性与帕金森病(PD)患者运动性左旋多巴诱导并发症(MLIC)发生的相关性。

材料与方法

我们研究了 76 例 PD 患者(MLIC 发生率为 56.6%)和 60 例对照者。对 rs6265BDNF(Val66Met)、rs397595DAT(SLC6A3)和 rs4680COMT(Val158Met)基因的等位基因进行了鉴别。使用多项逻辑回归计算比值比(OR)和 95%置信区间(95%CI)。采用正交偏最小二乘法(OPLS)分析和 OPLS 判别分析(OPLS-DA)分析定性遗传数据。

结果

携带 BDNF 基因型 AG 的 PD 患者的发病风险增加了 6 倍(OR=6.12,95%CI=2.88-13.02,p<0.0001),AGBDNF 和 AGDAT 基因型在 OPLS-DA 中与 PD 相关(VIP>1)。在伴有和不伴有 MLIC 的 PD 患者组中,BDNF、DAT 和 COMT 基因型的分布无差异,而 OPLS 模型显示,AGBDNF、AGDAT 和 GGCONT 基因型组合与 MLIC 相关,GGBDNF、AADAT 和 AA COMT 基因型组合与 PD 患者缺乏 MLIC 相关(VIP>1)。

结论

本研究结果证实了 rs6265BDNF(Val66Met)与 PD 风险的相关性,并提示 rs6265BDNF(Val66Met)、rs397595DAT(SLC6A3)和 rs4680COMT(Val158Met)多态性的协同作用可能与 MLIC 的发生有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7051/7066344/1ac2525ada85/BRB3-10-e01537-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7051/7066344/1ac2525ada85/BRB3-10-e01537-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7051/7066344/1ac2525ada85/BRB3-10-e01537-g001.jpg

相似文献

1
Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.基因多态性与帕金森病运动性左旋多巴诱导并发症。
Brain Behav. 2020 Mar;10(3):e01537. doi: 10.1002/brb3.1537. Epub 2020 Feb 5.
2
Association between the Val66Met (rs6265) polymorphism of the brain-derived neurotrophic factor (BDNF) gene, BDNF protein level in the blood and the risk of developing early‑onset Parkinson's disease.脑源性神经营养因子(BDNF)基因 Val66Met(rs6265)多态性、血液 BDNF 蛋白水平与早发性帕金森病发病风险的关系。
Acta Neurobiol Exp (Wars). 2024 Oct 11;84(3):296-308. doi: 10.55782/ane-2024-2476.
3
Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis.多巴胺代谢和信号通路的多态性与帕金森病运动性左旋多巴诱导并发症(MLIC)的易感性有关:系统评价和荟萃分析。
Neurol Sci. 2022 Jun;43(6):3649-3670. doi: 10.1007/s10072-021-05829-4. Epub 2022 Jan 25.
4
Influence of single nucleotide polymorphisms in COMT, MAO-A and BDNF genes on dyskinesias and levodopa use in Parkinson's disease.COMT、MAO-A 和 BDNF 基因单核苷酸多态性对帕金森病运动障碍和左旋多巴使用的影响。
Neurodegener Dis. 2014;13(1):24-8. doi: 10.1159/000351097. Epub 2013 Sep 5.
5
Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson's Disease: A Meta-Analysis and Systematic Review.儿茶酚-O-甲基转移酶基因 rs4680 多态性与帕金森病左旋多巴诱导运动障碍的关联:Meta 分析和系统评价。
J Geriatr Psychiatry Neurol. 2023 Mar;36(2):98-106. doi: 10.1177/08919887221103580. Epub 2022 May 22.
6
MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.MAO-B 和 COMT 基因变异与帕金森病患者左旋多巴治疗反应的相关性。
J Clin Pharmacol. 2018 Jul;58(7):920-926. doi: 10.1002/jcph.1096. Epub 2018 Mar 26.
7
Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia.儿茶酚-O-甲基转移酶(COMT)基因多态性与左旋多巴诱发异动症易感性的关系
J Pharm Pharm Sci. 2018;21(1):340-346. doi: 10.18433/jpps29903.
8
Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.基于人群的队列研究:帕金森病患者左旋多巴治疗诱导运动障碍的药物遗传学特征和发病机制。
Mol Biol Rep. 2020 Nov;47(11):8997-9004. doi: 10.1007/s11033-020-05956-9. Epub 2020 Nov 5.
9
The catechol-O-methyltransferase and monoamine oxidase B polymorphisms and levodopa therapy in the Iranian patients with sporadic Parkinson's disease.伊朗散发性帕金森病患者中儿茶酚-O-甲基转移酶和单胺氧化酶B基因多态性与左旋多巴治疗
Acta Neurobiol Exp (Wars). 2012;72(3):272-82. doi: 10.55782/ane-2012-1900.
10
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.功能性儿茶酚-O-甲基转移酶单倍型与帕金森病风险、左旋多巴治疗反应及并发症的关联。
Pharmacogenet Genomics. 2008 Sep;18(9):815-21. doi: 10.1097/FPC.0b013e328306c2f2.

引用本文的文献

1
Multigenetic pharmacogenomics-guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson's disease: a small real-word prospective cohort study.多基因药物基因组学指导的治疗在帕金森病中比常规治疗在运动症状方面显示出更大改善:一项小型真实世界前瞻性队列研究。
Front Pharmacol. 2025 Mar 25;16:1502379. doi: 10.3389/fphar.2025.1502379. eCollection 2025.
2
Targeting the RUNX3-miR-186-3p-DAT-IGF1R axis as a therapeutic strategy in a Parkinson's disease model.靶向 RUNX3-miR-186-3p-DAT-IGF1R 轴作为帕金森病模型中的治疗策略。
J Transl Med. 2024 Aug 5;22(1):719. doi: 10.1186/s12967-024-05535-7.
3

本文引用的文献

1
Motor complications in an incident Parkinson's disease cohort.帕金森病新发队列中的运动并发症
Eur J Neurol. 2016 Feb;23(2):304-12. doi: 10.1111/ene.12751. Epub 2015 Jun 13.
2
Meta-analysis study on the role of bone-derived neurotrophic factor Val66Met polymorphism in Parkinson's disease.骨源性神经营养因子Val66Met多态性在帕金森病中作用的Meta分析研究
Rejuvenation Res. 2015 Feb;18(1):40-7. doi: 10.1089/rej.2014.1612.
3
Catechol-O-methyltransferase Val158Met polymorphism: modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease.
Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats.
纹状体 5-羟色胺转运体功能获得性亢进在左旋多巴治疗的偏侧帕金森病大鼠中的作用。
Brain Res. 2023 Jul 15;1811:148381. doi: 10.1016/j.brainres.2023.148381. Epub 2023 Apr 29.
4
Association Between Dystonia-Related Genetic Loci and Parkinson's Disease in Eastern China.中国东部地区肌张力障碍相关基因位点与帕金森病的关联
Front Neurol. 2022 Feb 22;12:711050. doi: 10.3389/fneur.2021.711050. eCollection 2021.
5
Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson's Disease Pathogenesis: A Narrative Review.环境对帕金森病发病机制潜在表观遗传机制的影响:一篇叙述性综述
Brain Sci. 2022 Jan 28;12(2):175. doi: 10.3390/brainsci12020175.
6
Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis.多巴胺代谢和信号通路的多态性与帕金森病运动性左旋多巴诱导并发症(MLIC)的易感性有关:系统评价和荟萃分析。
Neurol Sci. 2022 Jun;43(6):3649-3670. doi: 10.1007/s10072-021-05829-4. Epub 2022 Jan 25.
7
Effect of Catechol-O-Methyltransferase Genotype Polymorphism on Neurological and Psychiatric Disorders: Progressing Towards Personalized Medicine.儿茶酚-O-甲基转移酶基因多态性对神经和精神疾病的影响:向个性化医疗迈进
Cureus. 2021 Sep 27;13(9):e18311. doi: 10.7759/cureus.18311. eCollection 2021 Sep.
8
Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson's disease-a meta-analysis.COMT rs4680 和 MAO-B rs1799836 多态性与帕金森病患者左旋多巴诱导的运动障碍的关联:一项荟萃分析。
Neurol Sci. 2021 Oct;42(10):4085-4094. doi: 10.1007/s10072-021-05509-3. Epub 2021 Aug 4.
9
Role of Liver Growth Factor (LGF) in Parkinson's Disease: Molecular Insights and Therapeutic Opportunities.肝生长因子(LGF)在帕金森病中的作用:分子见解和治疗机会。
Mol Neurobiol. 2021 Jul;58(7):3031-3042. doi: 10.1007/s12035-021-02326-9. Epub 2021 Feb 19.
儿茶酚-O-甲基转移酶Val158Met基因多态性:中国帕金森病队列中剂末现象易感性的调节
Parkinsonism Relat Disord. 2014 Oct;20(10):1094-6. doi: 10.1016/j.parkreldis.2014.07.011. Epub 2014 Jul 27.
4
Val158Met polymorphism of COMT gene and Parkinson's disease risk in Asians.亚洲人群中儿茶酚-O-甲基转移酶(COMT)基因Val158Met多态性与帕金森病风险
Neurol Sci. 2015 Jan;36(1):109-15. doi: 10.1007/s10072-014-1896-0. Epub 2014 Jul 25.
5
Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.中国人群中儿茶酚-O-甲基转移酶和单胺氧化酶B基因多态性与帕金森病运动并发症的关联
Parkinsonism Relat Disord. 2014 Oct;20(10):1041-5. doi: 10.1016/j.parkreldis.2014.06.021. Epub 2014 Jul 4.
6
COMT gene and risk for Parkinson's disease: a systematic review and meta-analysis.COMT 基因与帕金森病风险:系统评价和荟萃分析。
Pharmacogenet Genomics. 2014 Jul;24(7):331-9. doi: 10.1097/FPC.0000000000000056.
7
Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease.SLC6A3、DRD2 和 BDNF 基因中的序列变异与帕金森病患者左旋多巴诱导的运动障碍发生时间的关系。
J Mol Neurosci. 2014 Jun;53(2):183-8. doi: 10.1007/s12031-014-0276-9. Epub 2014 Mar 15.
8
BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.脑源性神经营养因子196 G/A和270 C/T多态性与帕金森病易感性:一项荟萃分析。
J Mot Behav. 2014;46(1):59-66. doi: 10.1080/00222895.2013.862199. Epub 2013 Dec 12.
9
Influence of single nucleotide polymorphisms in COMT, MAO-A and BDNF genes on dyskinesias and levodopa use in Parkinson's disease.COMT、MAO-A 和 BDNF 基因单核苷酸多态性对帕金森病运动障碍和左旋多巴使用的影响。
Neurodegener Dis. 2014;13(1):24-8. doi: 10.1159/000351097. Epub 2013 Sep 5.
10
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.帕金森病中左旋多巴诱导的运动障碍和开-关现象发展的预测因素。
Mov Disord. 2013 Jul;28(8):1064-71. doi: 10.1002/mds.25364. Epub 2013 Apr 29.